220 related articles for article (PubMed ID: 21676602)
1. [New antituberculosis vaccines].
Locht C; Rouanet C
Arch Pediatr; 2011 Sep; 18(9):1023-7. PubMed ID: 21676602
[TBL] [Abstract][Full Text] [Related]
2. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis: vaccines in the pipeline.
Ly LH; McMurray DN
Expert Rev Vaccines; 2008 Jul; 7(5):635-50. PubMed ID: 18564018
[TBL] [Abstract][Full Text] [Related]
4. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?
Martín C
Eur Respir J; 2005 Jul; 26(1):162-7. PubMed ID: 15994403
[TBL] [Abstract][Full Text] [Related]
5. New tuberculosis vaccines.
Martín Montañés C; Gicquel B
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
[TBL] [Abstract][Full Text] [Related]
6. Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates.
Franco-Paredes C; Rouphael N; del Rio C; Santos-Preciado JI
Int J Infect Dis; 2006 Mar; 10(2):93-102. PubMed ID: 16377228
[TBL] [Abstract][Full Text] [Related]
7. Boosting BCG to protect against TB.
Rouanet C; Locht C
Expert Rev Respir Med; 2010 Jun; 4(3):339-48. PubMed ID: 20524917
[TBL] [Abstract][Full Text] [Related]
8. Immunoprophylaxis of tuberculosis: an update of emerging trends.
Singhal N; Bisht D; Joshi B
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):97-106. PubMed ID: 20140756
[TBL] [Abstract][Full Text] [Related]
9. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.
Xing Z; Charters TJ
Expert Rev Vaccines; 2007 Aug; 6(4):539-46. PubMed ID: 17669008
[TBL] [Abstract][Full Text] [Related]
10. New vaccines for the prevention of tuberculosis.
von Reyn CF; Vuola JM
Clin Infect Dis; 2002 Aug; 35(4):465-74. PubMed ID: 12145732
[TBL] [Abstract][Full Text] [Related]
11. Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen.
Skeiky YA; Dietrich J; Lasco TM; Stagliano K; Dheenadhayalan V; Goetz MA; Cantarero L; Basaraba RJ; Bang P; Kromann I; McMclain JB; Sadoff JC; Andersen P
Vaccine; 2010 Jan; 28(4):1084-93. PubMed ID: 19896449
[TBL] [Abstract][Full Text] [Related]
12. Influence of BCG vaccine strain on the immune response and protection against tuberculosis.
Ritz N; Hanekom WA; Robins-Browne R; Britton WJ; Curtis N
FEMS Microbiol Rev; 2008 Aug; 32(5):821-41. PubMed ID: 18616602
[TBL] [Abstract][Full Text] [Related]
13. Antituberculous vaccine development: a perspective for the endemic world.
Verma I; Grover A
Expert Rev Vaccines; 2009 Nov; 8(11):1547-53. PubMed ID: 19863247
[TBL] [Abstract][Full Text] [Related]
14. Is intranasal vaccination a feasible solution for tuberculosis?
Giri PK; Khuller GK
Expert Rev Vaccines; 2008 Nov; 7(9):1341-56. PubMed ID: 18980538
[TBL] [Abstract][Full Text] [Related]
15. Advances in tuberculosis vaccine strategies.
Skeiky YA; Sadoff JC
Nat Rev Microbiol; 2006 Jun; 4(6):469-76. PubMed ID: 16710326
[TBL] [Abstract][Full Text] [Related]
16. Novel approaches to tuberculosis prevention: DNA vaccines.
Rivas-Santiago B; Cervantes-Villagrana AR
Scand J Infect Dis; 2014 Mar; 46(3):161-8. PubMed ID: 24450840
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing the protective efficacy of a BCG homologous prime-boost vaccination regime against tuberculosis.
Griffin JF; Mackintosh CG; Rodgers CR
Vaccine; 2006 Feb; 24(6):835-45. PubMed ID: 16098638
[TBL] [Abstract][Full Text] [Related]
18. Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.
van Dissel JT; Soonawala D; Joosten SA; Prins C; Arend SM; Bang P; Tingskov PN; Lingnau K; Nouta J; Hoff ST; Rosenkrands I; Kromann I; Ottenhoff TH; Doherty TM; Andersen P
Vaccine; 2011 Mar; 29(11):2100-9. PubMed ID: 21256189
[TBL] [Abstract][Full Text] [Related]
19. Cattle as a model for development of vaccines against human tuberculosis.
Buddle BM; Skinner MA; Wedlock DN; de Lisle GW; Vordermeier HM; Glyn Hewinson R
Tuberculosis (Edinb); 2005; 85(1-2):19-24. PubMed ID: 15687023
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides greater protective immunity against tuberculosis than the existing bacille Calmette-Guérin vaccine.
Pinto R; Saunders BM; Camacho LR; Britton WJ; Gicquel B; Triccas JA
J Infect Dis; 2004 Jan; 189(1):105-12. PubMed ID: 14702160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
